1,3-dipropyl-8-cyclopentylxanthine has been researched along with Alloxan Diabetes in 7 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine (ADO) has been implicated as a pathophysiological factor in contrast media (CM)-induced acute renal failure, which has been encountered more often in patients with diabetes and impaired renal function." | 1.29 | Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. ( Osswald, H; Pflueger, AC; Schenk, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takenaka, T | 1 |
| Inoue, T | 1 |
| Ohno, Y | 1 |
| Miyazaki, T | 1 |
| Nishiyama, A | 1 |
| Ishii, N | 1 |
| Suzuki, H | 1 |
| Patinha, D | 1 |
| Fasching, A | 1 |
| Pinho, D | 1 |
| Albino-Teixeira, A | 1 |
| Morato, M | 1 |
| Palm, F | 1 |
| Szczepańska-Konkel, M | 1 |
| Jankowski, M | 1 |
| Stiepanow-Trzeciak, A | 1 |
| Rudzik, A | 1 |
| Pawełczyk, T | 1 |
| Angielski, S | 1 |
| Pflueger, AC | 1 |
| Schenk, F | 1 |
| Osswald, H | 1 |
| Cassar, M | 1 |
| Jones, MG | 1 |
| Szatkowski, M | 1 |
| Cheng, JT | 1 |
| Chi, TC | 1 |
| Liu, IM | 1 |
| Saggerson, D | 1 |
| Orford, M | 1 |
| Chatzipanteli, K | 1 |
| Shepherd, J | 1 |
7 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Alloxan Diabetes
| Article | Year |
|---|---|
Elucidating mechanisms underlying altered renal autoregulation in diabetes.
Topics: Animals; Connexins; Diabetes Mellitus, Experimental; Disease Models, Animal; Glomerular Filtration R | 2012 |
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; | 2013 |
Responsiveness of renal glomeruli to adenosine in streptozotocin-induced diabetic rats dependent on hyperglycaemia level.
Topics: Adenosine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hemo | 2003 |
Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats.
Topics: Adenosine; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Pharmac | 1995 |
Reduced adenosine uptake accelerates ischaemic block of population spikes in hippocampal slices from streptozotocin-treated diabetic rats.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Brain Ischemia; Diabetes Mellitus, Experimen | 1998 |
Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats.
Topics: Adenosine; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Dipyridamole; Disea | 2000 |
Diabetes decreases sensitivity of adipocyte lipolysis to inhibition by Gi-linked receptor agonists.
Topics: Adipose Tissue; Animals; Cell Membrane; Colforsin; Diabetes Mellitus, Experimental; Dinoprostone; El | 1991 |